19 articles for S Hitchcock
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of 2-methylpyridine-based biaryl amides as¿-secretase modulators for the treatment of Alzheimer's disease.

Amgen
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of ß-Secretase.

TBA
Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.

Amgen
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson's Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate.

Takeda California
Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia.

Takeda California
Inhibitors of integrated stress response pathway

Praxis Biotech
JAK inhibitors containing a 4-membered heterocyclic amide

Theravance Biopharma R&D Ip
Dihydropyrrolopyridine inhibitors of ROR-gamma

Vitae Pharmaceuticals
4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment

Confluence Life Sciences
Inhibitory effect of novel pyrazole carboxamide derivatives on human carbonic anhydrase enzyme.

Dumlupinar University
Nicotinic receptor compounds

Research Triangle Institute
1,2,6-substituted benzimidazoles as flap modulators

Janssen Pharmaceutica
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

Sanofi
FAK inhibitors

Cancer Therapeutics Crc
Design and synthesis of newer potential 4-(N-acetylamino)phenol derived piperazine derivatives as potential cognition enhancers.

Panjab University
Amino tetrahydro-pyridopyrimidine PDE10 inhibitors

Merck Sharp & Dohme
17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases

Universitaet Des Saarlandes
Desensitization of the human motilin receptor by motilides.

Katholieke Universiteit Leuven
Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.

Montana State University